nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—CYP2B6—Simvastatin—atherosclerosis	0.142	0.34	CbGbCtD
Memantine—CYP2C19—Rosuvastatin—atherosclerosis	0.0971	0.232	CbGbCtD
Memantine—CYP2C19—Simvastatin—atherosclerosis	0.0903	0.216	CbGbCtD
Memantine—CYP2C19—Lovastatin—atherosclerosis	0.0884	0.211	CbGbCtD
Memantine—Tremor—Lovastatin—atherosclerosis	0.000659	0.00149	CcSEcCtD
Memantine—Visual impairment—Pravastatin—atherosclerosis	0.000658	0.00149	CcSEcCtD
Memantine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000652	0.00147	CcSEcCtD
Memantine—Eye disorder—Niacin—atherosclerosis	0.000648	0.00147	CcSEcCtD
Memantine—Flatulence—Simvastatin—atherosclerosis	0.000648	0.00146	CcSEcCtD
Memantine—Tinnitus—Niacin—atherosclerosis	0.000647	0.00146	CcSEcCtD
Memantine—Erythema multiforme—Pravastatin—atherosclerosis	0.000646	0.00146	CcSEcCtD
Memantine—Dysgeusia—Simvastatin—atherosclerosis	0.000644	0.00146	CcSEcCtD
Memantine—Flushing—Niacin—atherosclerosis	0.000644	0.00145	CcSEcCtD
Memantine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00064	0.00145	CcSEcCtD
Memantine—Anaemia—Ezetimibe—atherosclerosis	0.000638	0.00144	CcSEcCtD
Memantine—Tinnitus—Pravastatin—atherosclerosis	0.000637	0.00144	CcSEcCtD
Memantine—Malaise—Lovastatin—atherosclerosis	0.000634	0.00143	CcSEcCtD
Memantine—Flushing—Pravastatin—atherosclerosis	0.000634	0.00143	CcSEcCtD
Memantine—Cardiac disorder—Pravastatin—atherosclerosis	0.000634	0.00143	CcSEcCtD
Memantine—Vertigo—Lovastatin—atherosclerosis	0.000632	0.00143	CcSEcCtD
Memantine—Angiopathy—Niacin—atherosclerosis	0.000629	0.00142	CcSEcCtD
Memantine—Leukopenia—Lovastatin—atherosclerosis	0.000629	0.00142	CcSEcCtD
Memantine—Chills—Niacin—atherosclerosis	0.000623	0.00141	CcSEcCtD
Memantine—Malaise—Ezetimibe—atherosclerosis	0.000622	0.00141	CcSEcCtD
Memantine—Vision blurred—Simvastatin—atherosclerosis	0.00062	0.0014	CcSEcCtD
Memantine—Arrhythmia—Niacin—atherosclerosis	0.00062	0.0014	CcSEcCtD
Memantine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000617	0.00139	CcSEcCtD
Memantine—Tremor—Simvastatin—atherosclerosis	0.000616	0.00139	CcSEcCtD
Memantine—Alopecia—Niacin—atherosclerosis	0.000613	0.00139	CcSEcCtD
Memantine—Chills—Pravastatin—atherosclerosis	0.000613	0.00138	CcSEcCtD
Memantine—Insomnia—Rosuvastatin—atherosclerosis	0.000613	0.00138	CcSEcCtD
Memantine—Ill-defined disorder—Simvastatin—atherosclerosis	0.00061	0.00138	CcSEcCtD
Memantine—Arrhythmia—Pravastatin—atherosclerosis	0.00061	0.00138	CcSEcCtD
Memantine—Palpitations—Ezetimibe—atherosclerosis	0.00061	0.00138	CcSEcCtD
Memantine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000608	0.00137	CcSEcCtD
Memantine—Anaemia—Simvastatin—atherosclerosis	0.000608	0.00137	CcSEcCtD
Memantine—Malnutrition—Niacin—atherosclerosis	0.000604	0.00136	CcSEcCtD
Memantine—Alopecia—Pravastatin—atherosclerosis	0.000604	0.00136	CcSEcCtD
Memantine—Cough—Ezetimibe—atherosclerosis	0.000602	0.00136	CcSEcCtD
Memantine—Arthralgia—Lovastatin—atherosclerosis	0.000599	0.00135	CcSEcCtD
Memantine—Chest pain—Lovastatin—atherosclerosis	0.000599	0.00135	CcSEcCtD
Memantine—Myalgia—Lovastatin—atherosclerosis	0.000599	0.00135	CcSEcCtD
Memantine—Anxiety—Lovastatin—atherosclerosis	0.000597	0.00135	CcSEcCtD
Memantine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000596	0.00135	CcSEcCtD
Memantine—Hypertension—Ezetimibe—atherosclerosis	0.000596	0.00135	CcSEcCtD
Memantine—Flatulence—Niacin—atherosclerosis	0.000595	0.00134	CcSEcCtD
Memantine—Malaise—Simvastatin—atherosclerosis	0.000593	0.00134	CcSEcCtD
Memantine—Tension—Niacin—atherosclerosis	0.000593	0.00134	CcSEcCtD
Memantine—Discomfort—Lovastatin—atherosclerosis	0.000592	0.00134	CcSEcCtD
Memantine—Vertigo—Simvastatin—atherosclerosis	0.000591	0.00134	CcSEcCtD
Memantine—Leukopenia—Simvastatin—atherosclerosis	0.000589	0.00133	CcSEcCtD
Memantine—Chest pain—Ezetimibe—atherosclerosis	0.000587	0.00133	CcSEcCtD
Memantine—Arthralgia—Ezetimibe—atherosclerosis	0.000587	0.00133	CcSEcCtD
Memantine—Myalgia—Ezetimibe—atherosclerosis	0.000587	0.00133	CcSEcCtD
Memantine—Nervousness—Niacin—atherosclerosis	0.000587	0.00133	CcSEcCtD
Memantine—Flatulence—Pravastatin—atherosclerosis	0.000586	0.00132	CcSEcCtD
Memantine—Dry mouth—Lovastatin—atherosclerosis	0.000586	0.00132	CcSEcCtD
Memantine—Tension—Pravastatin—atherosclerosis	0.000584	0.00132	CcSEcCtD
Memantine—Dysgeusia—Pravastatin—atherosclerosis	0.000582	0.00132	CcSEcCtD
Memantine—Discomfort—Ezetimibe—atherosclerosis	0.00058	0.00131	CcSEcCtD
Memantine—Pain—Rosuvastatin—atherosclerosis	0.000579	0.00131	CcSEcCtD
Memantine—Constipation—Rosuvastatin—atherosclerosis	0.000579	0.00131	CcSEcCtD
Memantine—Confusional state—Lovastatin—atherosclerosis	0.000579	0.00131	CcSEcCtD
Memantine—Nervousness—Pravastatin—atherosclerosis	0.000578	0.00131	CcSEcCtD
Memantine—Dry mouth—Ezetimibe—atherosclerosis	0.000574	0.0013	CcSEcCtD
Memantine—Infection—Lovastatin—atherosclerosis	0.00057	0.00129	CcSEcCtD
Memantine—Vision blurred—Niacin—atherosclerosis	0.000569	0.00129	CcSEcCtD
Memantine—Confusional state—Ezetimibe—atherosclerosis	0.000568	0.00128	CcSEcCtD
Memantine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000562	0.00127	CcSEcCtD
Memantine—Vision blurred—Pravastatin—atherosclerosis	0.00056	0.00127	CcSEcCtD
Memantine—Chest pain—Simvastatin—atherosclerosis	0.00056	0.00127	CcSEcCtD
Memantine—Arthralgia—Simvastatin—atherosclerosis	0.00056	0.00127	CcSEcCtD
Memantine—Myalgia—Simvastatin—atherosclerosis	0.00056	0.00127	CcSEcCtD
Memantine—Infection—Ezetimibe—atherosclerosis	0.000559	0.00126	CcSEcCtD
Memantine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000558	0.00126	CcSEcCtD
Memantine—Anxiety—Simvastatin—atherosclerosis	0.000558	0.00126	CcSEcCtD
Memantine—Tremor—Pravastatin—atherosclerosis	0.000557	0.00126	CcSEcCtD
Memantine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000554	0.00125	CcSEcCtD
Memantine—Discomfort—Simvastatin—atherosclerosis	0.000553	0.00125	CcSEcCtD
Memantine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000552	0.00125	CcSEcCtD
Memantine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000552	0.00125	CcSEcCtD
Memantine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000551	0.00125	CcSEcCtD
Memantine—Anaemia—Pravastatin—atherosclerosis	0.00055	0.00124	CcSEcCtD
Memantine—Anorexia—Lovastatin—atherosclerosis	0.000547	0.00124	CcSEcCtD
Memantine—Skin disorder—Ezetimibe—atherosclerosis	0.000547	0.00124	CcSEcCtD
Memantine—Vertigo—Niacin—atherosclerosis	0.000543	0.00123	CcSEcCtD
Memantine—Syncope—Niacin—atherosclerosis	0.000542	0.00122	CcSEcCtD
Memantine—Confusional state—Simvastatin—atherosclerosis	0.000541	0.00122	CcSEcCtD
Memantine—Leukopenia—Niacin—atherosclerosis	0.000541	0.00122	CcSEcCtD
Memantine—Urticaria—Rosuvastatin—atherosclerosis	0.000538	0.00122	CcSEcCtD
Memantine—Oedema—Simvastatin—atherosclerosis	0.000537	0.00121	CcSEcCtD
Memantine—Malaise—Pravastatin—atherosclerosis	0.000536	0.00121	CcSEcCtD
Memantine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000535	0.00121	CcSEcCtD
Memantine—Vertigo—Pravastatin—atherosclerosis	0.000534	0.00121	CcSEcCtD
Memantine—Palpitations—Niacin—atherosclerosis	0.000534	0.00121	CcSEcCtD
Memantine—Infection—Simvastatin—atherosclerosis	0.000533	0.00121	CcSEcCtD
Memantine—Leukopenia—Pravastatin—atherosclerosis	0.000532	0.0012	CcSEcCtD
Memantine—Loss of consciousness—Niacin—atherosclerosis	0.000531	0.0012	CcSEcCtD
Memantine—Cough—Niacin—atherosclerosis	0.000527	0.00119	CcSEcCtD
Memantine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000526	0.00119	CcSEcCtD
Memantine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000523	0.00118	CcSEcCtD
Memantine—Insomnia—Lovastatin—atherosclerosis	0.000519	0.00117	CcSEcCtD
Memantine—Cough—Pravastatin—atherosclerosis	0.000519	0.00117	CcSEcCtD
Memantine—Paraesthesia—Lovastatin—atherosclerosis	0.000515	0.00116	CcSEcCtD
Memantine—Myalgia—Niacin—atherosclerosis	0.000514	0.00116	CcSEcCtD
Memantine—Arthralgia—Niacin—atherosclerosis	0.000514	0.00116	CcSEcCtD
Memantine—Hypertension—Pravastatin—atherosclerosis	0.000513	0.00116	CcSEcCtD
Memantine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000513	0.00116	CcSEcCtD
Memantine—Anorexia—Simvastatin—atherosclerosis	0.000512	0.00116	CcSEcCtD
Memantine—Dyspnoea—Lovastatin—atherosclerosis	0.000512	0.00116	CcSEcCtD
Memantine—Insomnia—Ezetimibe—atherosclerosis	0.000509	0.00115	CcSEcCtD
Memantine—Arthralgia—Pravastatin—atherosclerosis	0.000506	0.00114	CcSEcCtD
Memantine—Chest pain—Pravastatin—atherosclerosis	0.000506	0.00114	CcSEcCtD
Memantine—Myalgia—Pravastatin—atherosclerosis	0.000506	0.00114	CcSEcCtD
Memantine—Paraesthesia—Ezetimibe—atherosclerosis	0.000505	0.00114	CcSEcCtD
Memantine—Dyspepsia—Lovastatin—atherosclerosis	0.000505	0.00114	CcSEcCtD
Memantine—Anxiety—Pravastatin—atherosclerosis	0.000505	0.00114	CcSEcCtD
Memantine—Dry mouth—Niacin—atherosclerosis	0.000503	0.00114	CcSEcCtD
Memantine—Dyspnoea—Ezetimibe—atherosclerosis	0.000502	0.00113	CcSEcCtD
Memantine—Discomfort—Pravastatin—atherosclerosis	0.0005	0.00113	CcSEcCtD
Memantine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000499	0.00113	CcSEcCtD
Memantine—Decreased appetite—Lovastatin—atherosclerosis	0.000499	0.00113	CcSEcCtD
Memantine—Dyspepsia—Ezetimibe—atherosclerosis	0.000496	0.00112	CcSEcCtD
Memantine—Fatigue—Lovastatin—atherosclerosis	0.000495	0.00112	CcSEcCtD
Memantine—Oedema—Niacin—atherosclerosis	0.000493	0.00111	CcSEcCtD
Memantine—Pain—Lovastatin—atherosclerosis	0.000491	0.00111	CcSEcCtD
Memantine—Constipation—Lovastatin—atherosclerosis	0.000491	0.00111	CcSEcCtD
Memantine—Confusional state—Pravastatin—atherosclerosis	0.000489	0.00111	CcSEcCtD
Memantine—Decreased appetite—Ezetimibe—atherosclerosis	0.000489	0.00111	CcSEcCtD
Memantine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000489	0.00111	CcSEcCtD
Memantine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000486	0.0011	CcSEcCtD
Memantine—Asthenia—Rosuvastatin—atherosclerosis	0.000486	0.0011	CcSEcCtD
Memantine—Insomnia—Simvastatin—atherosclerosis	0.000486	0.0011	CcSEcCtD
Memantine—Oedema—Pravastatin—atherosclerosis	0.000485	0.0011	CcSEcCtD
Memantine—Fatigue—Ezetimibe—atherosclerosis	0.000485	0.0011	CcSEcCtD
Memantine—Shock—Niacin—atherosclerosis	0.000485	0.0011	CcSEcCtD
Memantine—Infection—Pravastatin—atherosclerosis	0.000482	0.00109	CcSEcCtD
Memantine—Paraesthesia—Simvastatin—atherosclerosis	0.000482	0.00109	CcSEcCtD
Memantine—Constipation—Ezetimibe—atherosclerosis	0.000481	0.00109	CcSEcCtD
Memantine—Pain—Ezetimibe—atherosclerosis	0.000481	0.00109	CcSEcCtD
Memantine—Tachycardia—Niacin—atherosclerosis	0.000481	0.00109	CcSEcCtD
Memantine—Pruritus—Rosuvastatin—atherosclerosis	0.000479	0.00108	CcSEcCtD
Memantine—Skin disorder—Niacin—atherosclerosis	0.000479	0.00108	CcSEcCtD
Memantine—Dyspnoea—Simvastatin—atherosclerosis	0.000479	0.00108	CcSEcCtD
Memantine—Hyperhidrosis—Niacin—atherosclerosis	0.000477	0.00108	CcSEcCtD
Memantine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000475	0.00107	CcSEcCtD
Memantine—Feeling abnormal—Lovastatin—atherosclerosis	0.000473	0.00107	CcSEcCtD
Memantine—Dyspepsia—Simvastatin—atherosclerosis	0.000473	0.00107	CcSEcCtD
Memantine—Anorexia—Niacin—atherosclerosis	0.00047	0.00106	CcSEcCtD
Memantine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000469	0.00106	CcSEcCtD
Memantine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000469	0.00106	CcSEcCtD
Memantine—Decreased appetite—Simvastatin—atherosclerosis	0.000467	0.00105	CcSEcCtD
Memantine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000464	0.00105	CcSEcCtD
Memantine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000463	0.00105	CcSEcCtD
Memantine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000463	0.00105	CcSEcCtD
Memantine—Fatigue—Simvastatin—atherosclerosis	0.000463	0.00105	CcSEcCtD
Memantine—Anorexia—Pravastatin—atherosclerosis	0.000463	0.00105	CcSEcCtD
Memantine—Hypotension—Niacin—atherosclerosis	0.000461	0.00104	CcSEcCtD
Memantine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00046	0.00104	CcSEcCtD
Memantine—Constipation—Simvastatin—atherosclerosis	0.000459	0.00104	CcSEcCtD
Memantine—Pain—Simvastatin—atherosclerosis	0.000459	0.00104	CcSEcCtD
Memantine—Urticaria—Lovastatin—atherosclerosis	0.000456	0.00103	CcSEcCtD
Memantine—Abdominal pain—Lovastatin—atherosclerosis	0.000454	0.00103	CcSEcCtD
Memantine—Body temperature increased—Lovastatin—atherosclerosis	0.000454	0.00103	CcSEcCtD
Memantine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000449	0.00101	CcSEcCtD
Memantine—Dizziness—Rosuvastatin—atherosclerosis	0.000448	0.00101	CcSEcCtD
Memantine—Urticaria—Ezetimibe—atherosclerosis	0.000447	0.00101	CcSEcCtD
Memantine—Insomnia—Niacin—atherosclerosis	0.000446	0.00101	CcSEcCtD
Memantine—Abdominal pain—Ezetimibe—atherosclerosis	0.000445	0.00101	CcSEcCtD
Memantine—Body temperature increased—Ezetimibe—atherosclerosis	0.000445	0.00101	CcSEcCtD
Memantine—Paraesthesia—Niacin—atherosclerosis	0.000443	0.001	CcSEcCtD
Memantine—Feeling abnormal—Simvastatin—atherosclerosis	0.000442	0.001	CcSEcCtD
Memantine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000442	0.000999	CcSEcCtD
Memantine—Dyspnoea—Niacin—atherosclerosis	0.000439	0.000993	CcSEcCtD
Memantine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000439	0.000992	CcSEcCtD
Memantine—Insomnia—Pravastatin—atherosclerosis	0.000439	0.000992	CcSEcCtD
Memantine—Somnolence—Niacin—atherosclerosis	0.000438	0.00099	CcSEcCtD
Memantine—Paraesthesia—Pravastatin—atherosclerosis	0.000436	0.000985	CcSEcCtD
Memantine—Dyspepsia—Niacin—atherosclerosis	0.000434	0.00098	CcSEcCtD
Memantine—Dyspnoea—Pravastatin—atherosclerosis	0.000433	0.000978	CcSEcCtD
Memantine—Decreased appetite—Niacin—atherosclerosis	0.000429	0.000968	CcSEcCtD
Memantine—Dyspepsia—Pravastatin—atherosclerosis	0.000427	0.000965	CcSEcCtD
Memantine—Rash—Rosuvastatin—atherosclerosis	0.000427	0.000965	CcSEcCtD
Memantine—Dermatitis—Rosuvastatin—atherosclerosis	0.000427	0.000964	CcSEcCtD
Memantine—Urticaria—Simvastatin—atherosclerosis	0.000426	0.000964	CcSEcCtD
Memantine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000426	0.000962	CcSEcCtD
Memantine—Body temperature increased—Simvastatin—atherosclerosis	0.000424	0.000959	CcSEcCtD
Memantine—Abdominal pain—Simvastatin—atherosclerosis	0.000424	0.000959	CcSEcCtD
Memantine—Headache—Rosuvastatin—atherosclerosis	0.000424	0.000959	CcSEcCtD
Memantine—Hypersensitivity—Lovastatin—atherosclerosis	0.000423	0.000955	CcSEcCtD
Memantine—Decreased appetite—Pravastatin—atherosclerosis	0.000422	0.000953	CcSEcCtD
Memantine—Pain—Niacin—atherosclerosis	0.000422	0.000952	CcSEcCtD
Memantine—Fatigue—Pravastatin—atherosclerosis	0.000418	0.000945	CcSEcCtD
Memantine—Constipation—Pravastatin—atherosclerosis	0.000415	0.000938	CcSEcCtD
Memantine—Pain—Pravastatin—atherosclerosis	0.000415	0.000938	CcSEcCtD
Memantine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000415	0.000937	CcSEcCtD
Memantine—Asthenia—Lovastatin—atherosclerosis	0.000412	0.00093	CcSEcCtD
Memantine—Pruritus—Lovastatin—atherosclerosis	0.000406	0.000917	CcSEcCtD
Memantine—Asthenia—Ezetimibe—atherosclerosis	0.000404	0.000913	CcSEcCtD
Memantine—Gastrointestinal pain—Niacin—atherosclerosis	0.000403	0.000911	CcSEcCtD
Memantine—Nausea—Rosuvastatin—atherosclerosis	0.000402	0.000909	CcSEcCtD
Memantine—Feeling abnormal—Pravastatin—atherosclerosis	0.0004	0.000904	CcSEcCtD
Memantine—Pruritus—Ezetimibe—atherosclerosis	0.000398	0.0009	CcSEcCtD
Memantine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000397	0.000897	CcSEcCtD
Memantine—Hypersensitivity—Simvastatin—atherosclerosis	0.000396	0.000894	CcSEcCtD
Memantine—Diarrhoea—Lovastatin—atherosclerosis	0.000393	0.000887	CcSEcCtD
Memantine—Urticaria—Niacin—atherosclerosis	0.000392	0.000885	CcSEcCtD
Memantine—Abdominal pain—Niacin—atherosclerosis	0.00039	0.00088	CcSEcCtD
Memantine—Body temperature increased—Niacin—atherosclerosis	0.00039	0.00088	CcSEcCtD
Memantine—Urticaria—Pravastatin—atherosclerosis	0.000386	0.000871	CcSEcCtD
Memantine—Asthenia—Simvastatin—atherosclerosis	0.000385	0.00087	CcSEcCtD
Memantine—Diarrhoea—Ezetimibe—atherosclerosis	0.000385	0.00087	CcSEcCtD
Memantine—Abdominal pain—Pravastatin—atherosclerosis	0.000384	0.000867	CcSEcCtD
Memantine—Body temperature increased—Pravastatin—atherosclerosis	0.000384	0.000867	CcSEcCtD
Memantine—Pruritus—Simvastatin—atherosclerosis	0.00038	0.000858	CcSEcCtD
Memantine—Dizziness—Lovastatin—atherosclerosis	0.00038	0.000858	CcSEcCtD
Memantine—Dizziness—Ezetimibe—atherosclerosis	0.000372	0.000841	CcSEcCtD
Memantine—Diarrhoea—Simvastatin—atherosclerosis	0.000367	0.00083	CcSEcCtD
Memantine—Vomiting—Lovastatin—atherosclerosis	0.000365	0.000825	CcSEcCtD
Memantine—Hypersensitivity—Niacin—atherosclerosis	0.000363	0.000821	CcSEcCtD
Memantine—Rash—Lovastatin—atherosclerosis	0.000362	0.000818	CcSEcCtD
Memantine—Dermatitis—Lovastatin—atherosclerosis	0.000362	0.000817	CcSEcCtD
Memantine—Headache—Lovastatin—atherosclerosis	0.00036	0.000812	CcSEcCtD
Memantine—Vomiting—Ezetimibe—atherosclerosis	0.000358	0.000809	CcSEcCtD
Memantine—Hypersensitivity—Pravastatin—atherosclerosis	0.000358	0.000808	CcSEcCtD
Memantine—Dizziness—Simvastatin—atherosclerosis	0.000355	0.000802	CcSEcCtD
Memantine—Rash—Ezetimibe—atherosclerosis	0.000355	0.000802	CcSEcCtD
Memantine—Dermatitis—Ezetimibe—atherosclerosis	0.000355	0.000801	CcSEcCtD
Memantine—Asthenia—Niacin—atherosclerosis	0.000354	0.000799	CcSEcCtD
Memantine—Headache—Ezetimibe—atherosclerosis	0.000353	0.000797	CcSEcCtD
Memantine—Pruritus—Niacin—atherosclerosis	0.000349	0.000788	CcSEcCtD
Memantine—Asthenia—Pravastatin—atherosclerosis	0.000348	0.000787	CcSEcCtD
Memantine—Pruritus—Pravastatin—atherosclerosis	0.000343	0.000776	CcSEcCtD
Memantine—Vomiting—Simvastatin—atherosclerosis	0.000341	0.000771	CcSEcCtD
Memantine—Nausea—Lovastatin—atherosclerosis	0.000341	0.00077	CcSEcCtD
Memantine—Rash—Simvastatin—atherosclerosis	0.000338	0.000765	CcSEcCtD
Memantine—Dermatitis—Simvastatin—atherosclerosis	0.000338	0.000764	CcSEcCtD
Memantine—Diarrhoea—Niacin—atherosclerosis	0.000337	0.000762	CcSEcCtD
Memantine—Headache—Simvastatin—atherosclerosis	0.000336	0.00076	CcSEcCtD
Memantine—Nausea—Ezetimibe—atherosclerosis	0.000334	0.000756	CcSEcCtD
Memantine—Diarrhoea—Pravastatin—atherosclerosis	0.000332	0.00075	CcSEcCtD
Memantine—Dizziness—Niacin—atherosclerosis	0.000326	0.000737	CcSEcCtD
Memantine—Dizziness—Pravastatin—atherosclerosis	0.000321	0.000725	CcSEcCtD
Memantine—Nausea—Simvastatin—atherosclerosis	0.000319	0.00072	CcSEcCtD
Memantine—Vomiting—Niacin—atherosclerosis	0.000313	0.000708	CcSEcCtD
Memantine—Rash—Niacin—atherosclerosis	0.000311	0.000702	CcSEcCtD
Memantine—Dermatitis—Niacin—atherosclerosis	0.000311	0.000702	CcSEcCtD
Memantine—Headache—Niacin—atherosclerosis	0.000309	0.000698	CcSEcCtD
Memantine—Vomiting—Pravastatin—atherosclerosis	0.000309	0.000697	CcSEcCtD
Memantine—Rash—Pravastatin—atherosclerosis	0.000306	0.000691	CcSEcCtD
Memantine—Dermatitis—Pravastatin—atherosclerosis	0.000306	0.000691	CcSEcCtD
Memantine—Headache—Pravastatin—atherosclerosis	0.000304	0.000687	CcSEcCtD
Memantine—Nausea—Niacin—atherosclerosis	0.000293	0.000662	CcSEcCtD
Memantine—Nausea—Pravastatin—atherosclerosis	0.000288	0.000651	CcSEcCtD
Memantine—CYP2B6—Metabolism—APOA4—atherosclerosis	5.21e-05	0.000373	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APOA4—atherosclerosis	5.19e-05	0.000372	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ALOX5—atherosclerosis	5.14e-05	0.000369	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—BGN—atherosclerosis	5.13e-05	0.000368	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TNF—atherosclerosis	5.12e-05	0.000367	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP7A1—atherosclerosis	5.11e-05	0.000367	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—APOA5—atherosclerosis	5.08e-05	0.000364	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	5.03e-05	0.00036	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCR2—atherosclerosis	5e-05	0.000358	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EDNRA—atherosclerosis	5e-05	0.000358	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	4.98e-05	0.000357	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	4.95e-05	0.000355	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PLA2G1B—atherosclerosis	4.89e-05	0.000351	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GHRL—atherosclerosis	4.87e-05	0.000349	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CCL2—atherosclerosis	4.8e-05	0.000344	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCL4—atherosclerosis	4.78e-05	0.000343	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP27A1—atherosclerosis	4.73e-05	0.000339	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ALOX5—atherosclerosis	4.72e-05	0.000339	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—KNG1—atherosclerosis	4.71e-05	0.000337	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AGTR1—atherosclerosis	4.68e-05	0.000335	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NAMPT—atherosclerosis	4.61e-05	0.000331	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—LIPC—atherosclerosis	4.59e-05	0.000329	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—APOC3—atherosclerosis	4.56e-05	0.000327	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—LDLR—atherosclerosis	4.53e-05	0.000325	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	4.48e-05	0.000321	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—APOA2—atherosclerosis	4.48e-05	0.000321	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PLA2G2A—atherosclerosis	4.48e-05	0.000321	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALOX5AP—atherosclerosis	4.48e-05	0.000321	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALOX15—atherosclerosis	4.48e-05	0.000321	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APOA2—atherosclerosis	4.46e-05	0.00032	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ABCG5—atherosclerosis	4.43e-05	0.000317	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CETP—atherosclerosis	4.42e-05	0.000317	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—LPA—atherosclerosis	4.28e-05	0.000306	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—KNG1—atherosclerosis	4.28e-05	0.000306	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ABCG1—atherosclerosis	4.26e-05	0.000306	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—UTS2—atherosclerosis	4.26e-05	0.000305	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AGTR1—atherosclerosis	4.25e-05	0.000305	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SCARB1—atherosclerosis	4.24e-05	0.000304	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NAMPT—atherosclerosis	4.24e-05	0.000304	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—IL6—atherosclerosis	4.23e-05	0.000304	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—LIPC—atherosclerosis	4.21e-05	0.000302	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—APOC3—atherosclerosis	4.18e-05	0.0003	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—LDLR—atherosclerosis	4.16e-05	0.000298	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—BGN—atherosclerosis	4.14e-05	0.000297	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—IL6—atherosclerosis	4.13e-05	0.000296	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—APOA5—atherosclerosis	4.1e-05	0.000294	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CX3CR1—atherosclerosis	4.08e-05	0.000293	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CASR—atherosclerosis	4.08e-05	0.000293	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CETP—atherosclerosis	4.06e-05	0.000291	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—FABP4—atherosclerosis	4.01e-05	0.000287	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—LCAT—atherosclerosis	4.01e-05	0.000287	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CX3CL1—atherosclerosis	4e-05	0.000287	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—HMGCR—atherosclerosis	4e-05	0.000287	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—IL6—atherosclerosis	3.99e-05	0.000286	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—EDN1—atherosclerosis	3.97e-05	0.000284	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PLA2G1B—atherosclerosis	3.95e-05	0.000283	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CCL5—atherosclerosis	3.94e-05	0.000282	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APOA4—atherosclerosis	3.93e-05	0.000282	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ALB—atherosclerosis	3.92e-05	0.000281	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—AKT1—atherosclerosis	3.91e-05	0.00028	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SCARB1—atherosclerosis	3.89e-05	0.000279	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP7A1—atherosclerosis	3.86e-05	0.000277	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALOX5—atherosclerosis	3.81e-05	0.000273	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—AKT1—atherosclerosis	3.81e-05	0.000273	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CNR2—atherosclerosis	3.8e-05	0.000272	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CXCL8—atherosclerosis	3.79e-05	0.000272	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MMP3—atherosclerosis	3.79e-05	0.000272	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PRKCG—atherosclerosis	3.74e-05	0.000268	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.68e-05	0.000264	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—HMGCR—atherosclerosis	3.67e-05	0.000263	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EDN1—atherosclerosis	3.6e-05	0.000258	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCL5—atherosclerosis	3.57e-05	0.000256	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP27A1—atherosclerosis	3.57e-05	0.000256	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ABCA1—atherosclerosis	3.57e-05	0.000256	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.52e-05	0.000252	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.43e-05	0.000246	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NAMPT—atherosclerosis	3.42e-05	0.000245	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PRKCG—atherosclerosis	3.4e-05	0.000244	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—LIPC—atherosclerosis	3.4e-05	0.000243	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PLA2G2A—atherosclerosis	3.39e-05	0.000243	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALOX5AP—atherosclerosis	3.39e-05	0.000243	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALOX15—atherosclerosis	3.39e-05	0.000243	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APOA2—atherosclerosis	3.39e-05	0.000243	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VWF—atherosclerosis	3.38e-05	0.000243	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—APOC3—atherosclerosis	3.38e-05	0.000242	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APOC3—atherosclerosis	3.36e-05	0.000241	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—LDLR—atherosclerosis	3.35e-05	0.000241	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ABCG5—atherosclerosis	3.35e-05	0.00024	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—LDLR—atherosclerosis	3.34e-05	0.00024	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.34e-05	0.00024	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AGT—atherosclerosis	3.29e-05	0.000236	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CETP—atherosclerosis	3.28e-05	0.000235	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ABCA1—atherosclerosis	3.27e-05	0.000235	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCL3—atherosclerosis	3.26e-05	0.000234	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—LPA—atherosclerosis	3.23e-05	0.000232	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SCARB1—atherosclerosis	3.14e-05	0.000225	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—BGN—atherosclerosis	3.13e-05	0.000224	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NCF1—atherosclerosis	3.13e-05	0.000224	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.11e-05	0.000223	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APOA5—atherosclerosis	3.1e-05	0.000222	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—HMOX1—atherosclerosis	3.06e-05	0.000219	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—F2—atherosclerosis	3.04e-05	0.000218	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.01e-05	0.000216	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AGT—atherosclerosis	2.99e-05	0.000214	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PLA2G1B—atherosclerosis	2.98e-05	0.000214	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—HMGCR—atherosclerosis	2.96e-05	0.000212	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EDNRA—atherosclerosis	2.95e-05	0.000212	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCR2—atherosclerosis	2.95e-05	0.000212	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.95e-05	0.000211	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CYBA—atherosclerosis	2.94e-05	0.000211	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—APOB—atherosclerosis	2.93e-05	0.00021	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.92e-05	0.000209	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.91e-05	0.000209	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CG—atherosclerosis	2.91e-05	0.000209	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALOX5—atherosclerosis	2.88e-05	0.000206	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PLAT—atherosclerosis	2.88e-05	0.000206	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PARP1—atherosclerosis	2.88e-05	0.000206	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GHRL—atherosclerosis	2.88e-05	0.000206	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTM1—atherosclerosis	2.85e-05	0.000204	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—HMOX1—atherosclerosis	2.81e-05	0.000201	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—LPL—atherosclerosis	2.8e-05	0.000201	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—F2—atherosclerosis	2.76e-05	0.000198	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GPX1—atherosclerosis	2.73e-05	0.000196	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—APOB—atherosclerosis	2.69e-05	0.000193	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.66e-05	0.000191	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CD36—atherosclerosis	2.66e-05	0.000191	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CG—atherosclerosis	2.64e-05	0.00019	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ABCA1—atherosclerosis	2.64e-05	0.000189	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTM1—atherosclerosis	2.62e-05	0.000188	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NAMPT—atherosclerosis	2.58e-05	0.000185	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—LPL—atherosclerosis	2.57e-05	0.000184	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.57e-05	0.000184	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—LIPC—atherosclerosis	2.57e-05	0.000184	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APOC3—atherosclerosis	2.55e-05	0.000183	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—LDLR—atherosclerosis	2.54e-05	0.000182	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KNG1—atherosclerosis	2.53e-05	0.000181	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—MTHFR—atherosclerosis	2.52e-05	0.000181	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AGTR1—atherosclerosis	2.51e-05	0.00018	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GPX1—atherosclerosis	2.51e-05	0.00018	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CETP—atherosclerosis	2.48e-05	0.000178	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPARA—atherosclerosis	2.47e-05	0.000177	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCL2—atherosclerosis	2.46e-05	0.000177	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PLG—atherosclerosis	2.45e-05	0.000175	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CD36—atherosclerosis	2.44e-05	0.000175	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AGT—atherosclerosis	2.39e-05	0.000172	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SCARB1—atherosclerosis	2.37e-05	0.00017	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—APOE—atherosclerosis	2.35e-05	0.000168	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CAV1—atherosclerosis	2.32e-05	0.000167	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—APOA1—atherosclerosis	2.32e-05	0.000166	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SOCS3—atherosclerosis	2.32e-05	0.000166	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—MTHFR—atherosclerosis	2.31e-05	0.000166	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.31e-05	0.000166	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPARA—atherosclerosis	2.27e-05	0.000163	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—HMOX1—atherosclerosis	2.27e-05	0.000162	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HMGCR—atherosclerosis	2.24e-05	0.000161	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MMP3—atherosclerosis	2.24e-05	0.00016	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF2—atherosclerosis	2.23e-05	0.00016	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AGT—atherosclerosis	2.2e-05	0.000158	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—APOB—atherosclerosis	2.17e-05	0.000156	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APOB—atherosclerosis	2.16e-05	0.000155	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—APOE—atherosclerosis	2.15e-05	0.000154	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCL8—atherosclerosis	2.14e-05	0.000154	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CAV1—atherosclerosis	2.13e-05	0.000153	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—APOA1—atherosclerosis	2.13e-05	0.000153	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EDN1—atherosclerosis	2.13e-05	0.000153	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CG—atherosclerosis	2.12e-05	0.000152	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCL5—atherosclerosis	2.11e-05	0.000151	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTM1—atherosclerosis	2.11e-05	0.000151	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—LPL—atherosclerosis	2.07e-05	0.000149	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—LPL—atherosclerosis	2.06e-05	0.000148	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPARG—atherosclerosis	2.04e-05	0.000146	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GPX1—atherosclerosis	2.02e-05	0.000145	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.02e-05	0.000145	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PRKCG—atherosclerosis	2.01e-05	0.000144	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—INS—atherosclerosis	2e-05	0.000144	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ABCA1—atherosclerosis	2e-05	0.000143	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CD36—atherosclerosis	1.97e-05	0.000141	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SPP1—atherosclerosis	1.96e-05	0.00014	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCL8—atherosclerosis	1.95e-05	0.00014	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CG—atherosclerosis	1.94e-05	0.000139	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPARG—atherosclerosis	1.88e-05	0.000134	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—MTHFR—atherosclerosis	1.87e-05	0.000134	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—INS—atherosclerosis	1.84e-05	0.000132	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ALB—atherosclerosis	1.84e-05	0.000132	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPARA—atherosclerosis	1.83e-05	0.000131	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PDGFB—atherosclerosis	1.81e-05	0.00013	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AGT—atherosclerosis	1.77e-05	0.000127	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AGT—atherosclerosis	1.77e-05	0.000127	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NOS3—atherosclerosis	1.76e-05	0.000126	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—APOE—atherosclerosis	1.74e-05	0.000125	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APOE—atherosclerosis	1.73e-05	0.000124	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—LEP—atherosclerosis	1.73e-05	0.000124	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CAV1—atherosclerosis	1.72e-05	0.000123	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—APOA1—atherosclerosis	1.72e-05	0.000123	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CAV1—atherosclerosis	1.71e-05	0.000123	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HMOX1—atherosclerosis	1.71e-05	0.000123	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APOA1—atherosclerosis	1.71e-05	0.000123	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ALB—atherosclerosis	1.69e-05	0.000121	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ESR1—atherosclerosis	1.65e-05	0.000118	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APOB—atherosclerosis	1.64e-05	0.000118	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—F2—atherosclerosis	1.63e-05	0.000117	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NOS3—atherosclerosis	1.61e-05	0.000116	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—atherosclerosis	1.61e-05	0.000115	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTM1—atherosclerosis	1.6e-05	0.000114	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CG—atherosclerosis	1.57e-05	0.000112	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—LPL—atherosclerosis	1.57e-05	0.000112	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CG—atherosclerosis	1.56e-05	0.000112	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GPX1—atherosclerosis	1.53e-05	0.00011	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPARG—atherosclerosis	1.51e-05	0.000108	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MAPK3—atherosclerosis	1.5e-05	0.000107	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CD36—atherosclerosis	1.49e-05	0.000107	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—INS—atherosclerosis	1.48e-05	0.000106	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—INS—atherosclerosis	1.48e-05	0.000106	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—atherosclerosis	1.48e-05	0.000106	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCL2—atherosclerosis	1.45e-05	0.000104	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF1—atherosclerosis	1.43e-05	0.000103	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—MTHFR—atherosclerosis	1.41e-05	0.000101	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPARA—atherosclerosis	1.38e-05	9.92e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALB—atherosclerosis	1.36e-05	9.75e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	1.36e-05	9.74e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AGT—atherosclerosis	1.34e-05	9.61e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APOE—atherosclerosis	1.31e-05	9.41e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NOS3—atherosclerosis	1.3e-05	9.33e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CAV1—atherosclerosis	1.3e-05	9.32e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APOA1—atherosclerosis	1.3e-05	9.3e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOS3—atherosclerosis	1.3e-05	9.3e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—atherosclerosis	1.19e-05	8.53e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CG—atherosclerosis	1.18e-05	8.49e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCL8—atherosclerosis	1.15e-05	8.25e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPARG—atherosclerosis	1.14e-05	8.2e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—INS—atherosclerosis	1.12e-05	8.04e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	1.11e-05	7.97e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL6—atherosclerosis	1.09e-05	7.84e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MMP9—atherosclerosis	1.04e-05	7.46e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NFKB1—atherosclerosis	1.03e-05	7.38e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALB—atherosclerosis	1.03e-05	7.37e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAPK8—atherosclerosis	1.01e-05	7.25e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT1—atherosclerosis	1.01e-05	7.23e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NOS3—atherosclerosis	9.84e-06	7.05e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—atherosclerosis	9.34e-06	6.7e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—STAT3—atherosclerosis	9.25e-06	6.63e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—atherosclerosis	9e-06	6.45e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAPK3—atherosclerosis	8.84e-06	6.34e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TGFB1—atherosclerosis	8.57e-06	6.15e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKT1—atherosclerosis	8.08e-06	5.79e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKT1—atherosclerosis	7.42e-06	5.32e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL6—atherosclerosis	6.46e-06	4.63e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKT1—atherosclerosis	5.98e-06	4.29e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT1—atherosclerosis	5.96e-06	4.27e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKT1—atherosclerosis	4.52e-06	3.24e-05	CbGpPWpGaD
